Photo from left to right: Alison Kawai, Mary Anthony, RTI International President and CEO, Tim Gabel, Bradley Layton, and Christine Bui. Not shown: Xabier Garcia de Albeniz
A group of RTI Health Solutions researchers was recently recognized by the wider RTI organization for their contributions to a body of research. The researchers were part of an FDA Center for Biologics Evaluation and Research (CBER) COVID-19 Vaccine Safety & Effectiveness Studies Team collaboration.
The President’s Award was established by former RTI President Tom Wooten in 1997 to recognize teams and individuals for significant contributions to RTI’s strategic goals in areas such as scientific stature, reputation, and impact.
To see more about our work with FDA CBER, click here.